Arginase inhibition improves coronary microvascular function and reduces infarct size following ischaemia-reperfusion in a rat model

Acta Physiologica

Volumn 208, Issue 2, 2013, Pages 172-179

  Gronros J ^a   Kiss, A ^a   Palmer M ^b   Jung, C ^a   Berkowitz, D ^c   Pernow, J ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arginase; Coronary artery; Microvascular function; Nitric oxide; Reperfusion

Indexed keywords

ARGINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY LIGATION; ENZYME ACTIVITY; ENZYME INHIBITION; FLOW RATE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ANIMALS; ARGINASE; ARGININE; CORONARY VESSELS; MYOCARDIAL INFARCTION; NITRIC OXIDE; RATS; REPERFUSION INJURY;

EID: 84877709833     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/apha.12097     Document Type: Article

References (25)

1. Ambrosio, G. & Tritto, I. 1999. Reperfusion injury: experimental evidence and clinical implications. Am Heart J 138, S69-S75.
2. Berkowitz, D.E., White, R., Li, D., Minhas, K.M., Cernetich, A., Kim, S., Burke, S., Shoukas, A.A., Nyhan, D., Champion, H.C. & Hare, J.M. 2003. Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels. Circulation 108, 2000-2006.
3. Cohen, M.V., Yang, X.M. & Downey, J.M. 2006. Nitric oxide is a preconditioning mimetic and cardioprotectant and is the basis of many available infarct-sparing strategies. Cardiovasc Res 70, 231-239.
4. Donato, M. & Gelpi, R.J. 2003. Adenosine and cardioprotection during reperfusion-an overview. Mol Cell Biochem 251, 153-159.
5. Dong-bao, L., Qi, H., Zhi, L., Shan, W. & Wei-ying, J. 2010. Predictors and long-term prognosis of angiographic slow/no-reflow phenomenon during emergency percutaneous coronary intervention for ST-elevated acute myocardial infarction. Clin Cardiol 33, E7-E12.
6. Durante, W., Johnson, F.K. & Johnson, R.A. 2007. Arginase: a critical regulator of nitric oxide synthesis and vascular function. Clin Exp Pharmacol Physiol 34, 906-911.
7. Gonon, A.T., Jung, C., Katz, A., Westerblad, H., Shemyakin, A., Sjoquist, P.O., Lundberg, J.O. & Pernow, J. 2012. Local arginase inhibition during early reperfusion mediates cardioprotection via increased nitric oxide production. PLoS ONE 7, e42038.
8. Gronros, J., Jung, C., Lundberg, J.O., Cerrato, R., Ostenson, C.G. & Pernow, J. 2011. Arginase inhibition restores in vivo coronary microvascular function in type 2 diabetic rats. Am J Physiol Heart Circ Physiol 300, H1174-H1181.
9. Hein, T.W., Zhang, C., Wang, W., Chang, C.I., Thengchaisri, N. & Kuo, L. 2003. Ischemia-reperfusion selectively impairs nitric oxide-mediated dilation in coronary arterioles: counteracting role of arginase. FASEB J 17, 2328-2330.
10. Hroch, M., Havlinova, Z., Nobilis, M. & Chladek, J. 2012. HPLC determination of arginases inhibitor N-(omega)-hydroxy-nor-L-arginine using core-shell particle column and LC-MS/MS identification of principal metabolite in rat plasma. J Chromatogr B Analyt Technol Biomed Life Sci 880, 90-99.
11. Ishihara, M., Sato, H., Tateishi, H., Kawagoe, T., Yoshimura, M. & Muraoka, Y. 1993. Impaired coronary flow reserve immediately after coronary angioplasty in patients with acute myocardial infarction. Br Heart J 69, 288-292.
12. Ito, H. 2006. No-reflow phenomenon and prognosis in patients with acute myocardial infarction. Nat Clin Pract Cardiovasc Med 3, 499-506.
13. Iwakura, K., Ito, H., Takiuchi, S., Taniyama, Y., Nakatsuchi, Y., Negoro, S., Higashino, Y., Okamura, A., Masuyama, T., Hori, M., Fujii, K. & Minamino, T. 1996. Alternation in the coronary blood flow velocity pattern in patients with no reflow and reperfused acute myocardial infarction. Circulation 94, 1269-1275.
14. Jung, C., Gonon, A.T., Sjoquist, P.O., Lundberg, J.O. & Pernow, J. 2010. Arginase inhibition mediates cardioprotection during ischaemia-reperfusion. Cardiovasc Res 85, 147-154.
15. Larach, D.R. & Schuler, H.G. 1991. Direct vasodilation by sevoflurane, isoflurane, and halothane alters coronary flow reserve in the isolated rat heart. Anesthesiology 75, 268-278.
16. Mullenheim, J., Ebel, D., Frassdorf, J., Preckel, B., Thamer, V. & Schlack, W. 2002. Isoflurane preconditions myocardium against infarction via release of free radicals. Anesthesiology 96, 934-940.
17. Park, J.L. & Lucchesi, B.R. 1999. Mechanisms of myocardial reperfusion injury. Ann Thorac Surg 68, 1905-1912.
18. Parker, P.E., Bashour, F.A., Downey, H.F., Kechejian, S.J. & Williams, A.G. 1975. Coronary hemodynamics during reperfusion following acute coronary ligation in dogs. Am Heart J 90, 593-599.
19. Reffelmann, T. & Kloner, R.A. 2002. The "no-reflow" phenomenon: basic science and clinical correlates. Heart 87, 162-168.
20. Reffelmann, T., Hale, S.L., Dow, J.S. & Kloner, R.A. 2003. No-reflow phenomenon persists long-term after ischemia/reperfusion in the rat and predicts infarct expansion. Circulation 108, 2911-2917.
21. Shah, S.R., Hochberg, C.P., Pinto, D.S. & Gibson, C.M. 2007. Reperfusion strategies for ST-elevation myocardial infarction. Curr Cardiol Rep 9, 281-288.
22. Tian, F., Zhou, X., Wikstrom, J., Karlsson, H., Sjoland, H., Gan, L.M., Boren, J. & Akyurek, L.M. 2009. Protein disulfide isomerase increases in myocardial endothelial cells in mice exposed to chronic hypoxia: a stimulatory role in angiogenesis. Am J Physiol Heart Circ Physiol 297, H1078-H1086.
23. Wikstrom, J., Gronros, J., Bergstrom, G. & Gan, L. 2005. Functional and morphologic imaging of coronary Atherosclerosis in living mice using high-resolution color Doppler echocardiography and ultrasound biomicroscopy. J Am Coll Cardiol 46, 720-727.
24. Yamamoto, K., Ito, H., Iwakura, K., Kawano, S., Ikushima, M., Masuyama, T., Ogihara, T. & Fujii, K. 2002. Two different coronary blood flow velocity patterns in thrombolysis in myocardial infarction flow grade 2 in acute myocardial infarction: insight into mechanisms of microvascular dysfunction. J Am Coll Cardiol 40, 1755-1760.
25. Yellon, D.M. & Hausenloy, D.J. 2007. Myocardial reperfusion injury. N Engl J Med 357, 1121-1135.